Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

M01AC02 TENOXICAMUM CAPS. 20 mg

TENOXICAM LPH 20 mg 20 mg LABORMED PHARMA SA
M01AC02 TENOXICAMUM COMPR. 20 mg

TENOXICAM 20 mg 20 mg ARENA GROUP SA

M01AC02 TENOXICAMUM COMPR. FILM. 20 mg

NEO-ENDUSIX(R) 20 mg ANFARM HELLAS S.A.

PHARMACEUTICALS

TILCOTIL 20 mg ROCHE ROMANIA S.R.L.

M01AC02 TENOXICAMUM LIOF. + SOLV. PT. SOL. 20 mg

INJ.

NEO-ENDUSIX(R) 20 mg ANFARM HELLAS S.A.

PHARMACEUTICALS

M01AC02 TENOXICAMUM LIOF. ŞI SOLV. PT. SOL. 20 mg

INJ.

TILCOTIL 20 mg ROCHE ROMANIA S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 109 |M01AC06| MELOXICAMUM | |

|_______|_______|____________________________________________|_________________|
A se administra cu precauţie la pacienţii cu istoric de factori de risc sau afecţiuni gastrointestinale.